ID   IMa
AC   CVCL_M688
SY   IMA
DR   Cosmic; 1820649
DR   Wikidata; Q54897513
RX   DOI=10.1007/0-306-46861-1_8;
RX   PubMed=2878840;
RX   PubMed=6682628;
RX   PubMed=6683709;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=6683709).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C39991; Non-gestational ovarian choriocarcinoma
DI   ORDO; Orphanet_289356; Primary non-gestational choriocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
RX   DOI=10.1007/0-306-46861-1_8;
RA   Ganapathy V., Prasad P.D., Leibach F.H.;
RT   "Choriocarcinoma.";
RL   (In book chapter) Human cell culture. Vol. 2. Cancer cell lines part 2; Masters J.R.W., Palsson B.O. (eds.); pp.141-147; Kluwer Academic Publishers; New York; USA (1999).
//
RX   PubMed=2878840; DOI=10.1016/0020-7292(86)90088-3;
RA   Yamashita K., Nakamura T., Shimizu T., Katagiri M., Ikeda H.;
RT   "Expression of HLA class I and class II antigens in human
RT   choriocarcinoma cell lines.";
RL   Int. J. Gynaecol. Obstet. 24:301-307(1986).
//
RX   PubMed=6682628; DOI=10.1016/0002-9378(83)90927-4;
RA   Sekiya S., Kaiho T., Shirotake S., Iwasawa H., Takeda B.,
RA   Takamizawa H.;
RT   "Effect of methotrexate on the growth and human chorionic gonadotropin
RT   secretion of human choriocarcinoma cell lines in vitro.";
RL   Am. J. Obstet. Gynecol. 146:57-64(1983).
//
RX   PubMed=6683709; DOI=10.1007/BF02619596;
RA   Sekiya S., Kaiho T., Shirotake S., Iwasawa H., Inaba N., Kawata M.,
RA   Higaki K., Ishige H., Takamizawa H., Minamihisamatsu M., Kuwata T.;
RT   "Establishment and properties of a human choriocarcinoma cell line of
RT   ovarian origin.";
RL   In Vitro 19:489-494(1983).
//